Sweden Pharmaceuticals

AstraZeneca PLC (AZN)

Track

Over the past 90 days, AstraZeneca PLC recorded one insider transaction, consisting of a sale valued at approximately $2.21 million by an executive. This activity follows a period where the stock price declined by 14.4%. Recent insider activity has been characterized by this single divestment, contrasting with earlier periods of executive buying.
Ticker: AZN Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for AstraZeneca PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sharma Mani
See Remarks
1 sale — total 2,209,482 USD
Sale 20 May 2026
Value US$3,710,622.87 | Price 455.68 | Shares 2,894
Sale 18 Dec 2025
Value £4,005,776.72 | Price 428.10 | Shares 20,240
Sale 18 Dec 2025
Value £1,539,149.96 | Price 61.67 | Shares 36,945
Sale 12 Nov 2025
Value US$1,329,517.50 | Price 88.63 | Shares 15,000
Sale 12 Nov 2025
Value US$1,329,517.50 | Price 88.63 | Shares 15,000
Proposed sale 12 Nov 2025
Value US$1,333,200.00 | Price 88.88 | Shares 15,000
Buy 9 Sep 2025
Value US$735.42 | Price 81.05 | Shares 9
Sale 14 Aug 2025
Value £1,100,863.87 | Price 115.12 | Shares 9,563
Buy 30 Apr 2025
Value US$100,317.00 | Price 71.66 | Shares 1,400
Buy 19 Nov 2024
Value US$190,194.50 | Price 63.40 | Shares 3,000
Buy 19 Nov 2024
Value US$190,194.50 | Price 63.40 | Shares 3,000
Buy 15 Nov 2024
Value £200,607.04 | Price 100.30 | Shares 2,000
Buy 15 Nov 2024
Value £200,600.00 | Price 100.30 | Shares 2,000
Buy 14 Nov 2024
Value £2,040,600.00 | Price 102.03 | Shares 20,000
Buy 14 Nov 2024
Value £2,040,600.00 | Price 102.03 | Shares 20,000
Buy 13 Nov 2024
Value £99,665.12 | Price 101.70 | Shares 980
Buy 13 Nov 2024
Value £99,665.12 | Price 101.70 | Shares 980
Buy 13 Sep 2024
Value £117.93 | Price 0.06 | Shares 2,000
Buy 13 Sep 2024
Value £235,854.93 | Price 117.93 | Shares 2,000
Buy 12 Dec 2023
Value £49,623.16 | Price 101.90 | Shares 487
Buy 12 Dec 2023
Value £101.90 | Price 0.21 | Shares 487
Buy 22 Nov 2023
Value £101,700.00 | Price 101.70 | Shares 1,000
Buy 22 Nov 2023
Value £101,700.00 | Price 101.70 | Shares 1,000
Buy 21 Nov 2023
Value £101,052.24 | Price 101.05 | Shares 1,000
Buy 21 Nov 2023
Value £101,052.24 | Price 101.05 | Shares 1,000
Proposed sale 5 May 2023
Value US$1,476,749.40 | Price 75.85 | Shares 19,470
Sale 5 May 2023
Value US$1,456,550.70 | Price 74.81 | Shares 19,470
Sale 5 May 2023
Value US$1,456,550.70 | Price 74.81 | Shares 19,470
Buy 28 Apr 2023
Value £234,020.00 | Price 117.01 | Shares 2,000
Buy 28 Apr 2023
Value £234,020.00 | Price 117.01 | Shares 2,000
Proposed sale 22 Nov 2022
Value US$2,145,187.38 | Price 65.58 | Shares 32,711
Sale 22 Nov 2022
Value US$2,145,187.38 | Price 65.58 | Shares 32,711
Sale 22 Nov 2022
Value US$2,145,187.38 | Price 65.58 | Shares 32,711
Sale 19 May 2022
Value US$1,168,213.20 | Price 64.56 | Shares 18,095
Sale 19 May 2022
Value US$1,168,213.20 | Price 64.56 | Shares 18,095
Sale 5 May 2022
Value US$989,539.10 | Price 65.23 | Shares 15,170
Sale 5 May 2022
Value US$989,539.10 | Price 65.23 | Shares 15,170
Buy 13 Dec 2021
Value US$108,580.00 | Price 54.29 | Shares 2,000
Buy 21 Jul 2021
Value US$2,444,644.44 | Price 115.08 | Shares 21,243
Buy 11 Feb 2021
Value £0.00 | Price 0.00 | Shares 6,289
Buy 11 Feb 2021
Value £0.00 | Price 0.00 | Shares 107,715
Buy 16 Dec 2020
Value US$36,064.00 | Price 51.52 | Shares 700
Buy 16 Dec 2020
Value £99,840.00 | Price 76.80 | Shares 1,300
Buy 16 Dec 2020
Value £39,697.33 | Price 76.78 | Shares 517
Buy 16 Dec 2020
Value £99,887.50 | Price 76.25 | Shares 1,310
Buy 18 Mar 2020
Value US$38,320.00 | Price 38.32 | Shares 1,000
Buy 26 Feb 2020
Value US$48,000.00 | Price 48.00 | Shares 1,000
Buy 17 Feb 2020
Value £51,191.00 | Price 73.13 | Shares 700
Buy 7 May 2019
Value £493,000.00 | Price 58.00 | Shares 8,500
Buy 30 Apr 2019
Value £29,837.60 | Price 57.38 | Shares 520
Buy 29 Apr 2019
Value US$38,305.60 | Price 38.31 | Shares 1,000
Buy 29 Apr 2019
Value US$94,376.02 | Price 38.18 | Shares 2,472
Buy 29 Apr 2019
Value £996,160.50 | Price 58.26 | Shares 17,100
Buy 2 Feb 2018
Value £20,112.41 | Price 48.46 | Shares 415
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-22 2026-05-20 S Sale
Sharma Mani

See Remarks

Officer
2,894 +22.3%
455.68
US$3,710,623 		2,894 +22.3% 455.68 US$3,710,623
2025-12-22 2025-12-18 S Sale
2.5
Nazneen Rahman

Non-Executive Director

Executive Director
20,240
428.10
£4,005,777 		20,240 428.10 £4,005,777
2025-12-19 2025-12-18 S Sale
2.5
Nazneen Rahman

Member of the Board of Directors

Director
36,945
61.67
£1,539,150 		36,945 61.67 £1,539,150
2025-11-14 2025-11-12 S Sale
1.3
Aradhana Sarin

Chief Financial Officer

Officer
15,000
88.63
US$1,329,518 		15,000 88.63 US$1,329,518
2025-11-14 2025-11-12 S Sale
1.3
Aradhana Sarin

Chief Financial Officer (CFO)

Officer
15,000
88.63
US$1,329,518 		15,000 88.63 US$1,329,518
2025-11-12 2025-11-12 PrS Proposed sale
ARADHANA SARIN

Officer

Officer
15,000
88.88
US$1,333,200 		15,000 88.88 US$1,333,200
2025-09-26 2025-09-09 B Purchase
Karen Knudsen

Member of the Board of Directors

Director
9
81.05
US$735 		9 81.05 US$735
2025-08-18 2025-08-14 S Sale
1.3
Aradhana Sarin

Chief Financial Officer (CFO)

Officer
9,563
115.12
£1,100,864 		9,563 115.12 £1,100,864
2025-05-02 2025-04-30 B Purchase
Karen Knudsen

Member of the Board of Directors

Director
1,400
71.66
US$100,317 		1,400 71.66 US$100,317
2024-11-21 2024-11-19 B Purchase
Tony Mok

Member of the Board of Directors

Director
3,000
63.40
US$190,195 		3,000 63.40 US$190,195
2024-11-20 2024-11-19 B Purchase
Tony Mok

Non-Executive Director

Executive Director
3,000
63.40
US$190,194 		3,000 63.40 US$190,194
2024-11-15 2024-11-15 B Purchase
3.1
Michel Demaré

Non-Executive Chair of the Board

Director
2,000
100.30
£200,607 		2,000 100.30 £200,607
2024-11-15 2024-11-15 B Purchase
3.1
Michel Demare

Chairman of the Board of Directors

Director
2,000
100.30
£200,600 		2,000 100.30 £200,600
2024-11-15 2024-11-14 B Purchase
3.6
Pascal Soriot

Chief Executive Officer

Officer
20,000
102.03
£2,040,600 		20,000 102.03 £2,040,600
2024-11-15 2024-11-14 B Purchase
3.6
Pascal Soriot

Chief Executive Officer (CEO)/Managing Directory

Officer
20,000
102.03
£2,040,600 		20,000 102.03 £2,040,600
2024-11-13 2024-11-13 B Purchase
3.5
Philip Broadley

Non-Executive Director

Executive Director
980
101.70
£99,665 		980 101.70 £99,665
2024-11-13 2024-11-13 B Purchase
3.5
Philip Broadley

Member of the Board of Directors

Director
980
101.70
£99,665 		980 101.70 £99,665
2024-09-13 2024-09-13 B Purchase
3.1
Michel Demaré

Non-Executive Chair of the Board

Director
2,000
0.06
£118 		2,000 0.06 £118
2024-09-13 2024-09-13 B Purchase
3.1
Michel Demare

Chairman of the Board of Directors

Director
2,000
117.93
£235,855 		2,000 117.93 £235,855
2023-12-18 2023-12-12 B Purchase
3.6
Anna Manz

Member of the Board of Directors

Director
487
101.90
£49,623 		487 101.90 £49,623
2023-12-14 2023-12-12 B Purchase
3.6
Anna Manz

Non-Executive Director

Executive Director
487
0.21
£102 		487 0.21 £102
2023-11-23 2023-11-22 B Purchase
3.1
Michel Demaré

Non-Executive Chair of the Board

Director
1,000
101.70
£101,700 		1,000 101.70 £101,700
2023-11-23 2023-11-22 B Purchase
3.1
Michel Demare

Chairman of the Board of Directors

Director
1,000
101.70
£101,700 		1,000 101.70 £101,700
2023-11-23 2023-11-21 B Purchase
3.1
Michel Demaré

Non-Executive Chair of the Board

Director
1,000
101.05
£101,052 		1,000 101.05 £101,052
2023-11-23 2023-11-21 B Purchase
3.1
Michel Demare

Chairman of the Board of Directors

Director
1,000
101.05
£101,052 		1,000 101.05 £101,052
2023-11-13 2023-05-05 PrS Proposed sale
Aradhana Sarin

Officer

Officer
19,470
75.85
US$1,476,749 		19,470 75.85 US$1,476,749
2023-05-09 2023-05-05 S Sale
1.3
Aradhana Sarin

Chief Financial Officer

Officer
19,470
74.81
US$1,456,551 		19,470 74.81 US$1,456,551
2023-05-09 2023-05-05 S Sale
1.3
Aradhana Sarin

Chief Financial Officer (CFO)

Officer
19,470
74.81
US$1,456,551 		19,470 74.81 US$1,456,551
2023-05-02 2023-04-28 B Purchase
3.1
Michel Demaré

Non-Executive Chair of the Board

Director
2,000
117.01
£234,020 		2,000 117.01 £234,020
2023-05-02 2023-04-28 B Purchase
3.1
Michel Demare

Chairman of the Board of Directors

Director
2,000
117.01
£234,020 		2,000 117.01 £234,020
2023-11-13 2022-11-22 PrS Proposed sale
Aradhana Sarin

Officer

Officer
32,711
65.58
US$2,145,187 		32,711 65.58 US$2,145,187
2022-11-23 2022-11-22 S Sale
1.3
Aradhana Sarin

Chief Financial Officer

Officer
32,711
65.58
US$2,145,187 		32,711 65.58 US$2,145,187
2022-11-23 2022-11-22 S Sale
1.3
Aradhana Sarin

Chief Financial Officer (CFO)

Officer
32,711
65.58
US$2,145,187 		32,711 65.58 US$2,145,187
2022-05-20 2022-05-19 S Sale
1.3
Aradhana Sarin

Chief Financial Officer

Officer
18,095
64.56
US$1,168,213 		18,095 64.56 US$1,168,213
2022-05-20 2022-05-19 S Sale
1.3
Aradhana Sarin

Chief Financial Officer (CFO)

Officer
18,095
64.56
US$1,168,213 		18,095 64.56 US$1,168,213
2022-05-06 2022-05-05 S Sale
Andreas Rummelt

Non-Executive Director

Executive Director
15,170
65.23
US$989,539 		15,170 65.23 US$989,539
2022-05-06 2022-05-05 S Sale
Andreas Rummelt

Member of the Board of Directors

Director
15,170
65.23
US$989,539 		15,170 65.23 US$989,539
2021-12-15 2021-12-13 B Purchase
Tony Mok

Non-Executive Director

Executive Director
2,000
54.29
US$108,580 		2,000 54.29 US$108,580
2021-07-21 2021-07-21 B Purchase
3.0
Marc Dunoyer

Chief Financial Officer

Officer
21,243
115.08
US$2,444,644 		21,243 115.08 US$2,444,644
2021-02-15 2021-02-11 B Purchase
3.0
Marc Dunoyer

Chief Financial Officer (CFO)

Officer
6,289
0.00
£0 		6,289 0.00 £0
2021-02-15 2021-02-11 B Purchase
3.6
Pascal Soriot

Chief Executive Officer (CEO)/Managing Directory

Officer
107,715
0.00
£0 		107,715 0.00 £0
2020-12-17 2020-12-16 B Purchase
Euan Ashley

Non-Executive Director

Executive Director
700
51.52
US$36,064 		700 51.52 US$36,064
2020-12-17 2020-12-16 B Purchase
3.1
Michel Demaré

Non-Executive Director

Executive Director
1,300
76.80
£99,840 		1,300 76.80 £99,840
2020-12-16 2020-12-16 B Purchase
2.5
Nazneen Rahman

Non-Executive Director

Executive Director
517
76.78
£39,697 		517 76.78 £39,697
2020-12-16 2020-12-16 B Purchase
3.5
Philip Broadley

Non-Executive Director

Executive Director
1,310
76.25
£99,888 		1,310 76.25 £99,888
2020-03-20 2020-03-18 B Purchase
Tony Mok

Non-Executive Director

Executive Director
1,000
38.32
US$38,320 		1,000 38.32 US$38,320
2020-02-27 2020-02-26 B Purchase
Tony Mok

Non-Executive Director

Executive Director
1,000
48.00
US$48,000 		1,000 48.00 US$48,000
2020-02-19 2020-02-17 B Purchase
3.1
Michel Demaré

Non-Executive Director

Executive Director
700
73.13
£51,191 		700 73.13 £51,191
2019-05-08 2019-05-07 B Purchase
3.0
Marc Dunoyer

Chief Financial Officer

Officer
8,500
58.00
£493,000 		8,500 58.00 £493,000
2019-05-01 2019-04-30 B Purchase
3.5
Philip Broadley

Non-Executive Director

Executive Director
520
57.38
£29,838 		520 57.38 £29,838
2019-05-01 2019-04-29 B Purchase
3.5
Deborah DiSanzo

Non-Executive Director

Executive Director
1,000
38.31
US$38,306 		1,000 38.31 US$38,306
2019-05-01 2019-04-29 B Purchase
Sheri McCoy

Non-Executive Director

Executive Director
2,472
38.18
US$94,376 		2,472 38.18 US$94,376
2019-05-01 2019-04-29 B Purchase
3.6
Pascal Soriot

Chief Executive Officer

Officer
17,100
58.26
£996,160 		17,100 58.26 £996,160
2018-02-05 2018-02-02 B Purchase
3.5
Philip Broadley

Non-Executive Director

Executive Director
415
48.46
£20,112 		415 48.46 £20,112
Explore more

More insider trading research around AstraZeneca PLC

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600